Table 2.

Study Indicators

STUDY INDICATORS
Resource utilization/health outcomes indicators*	- Number of unplanned diabetes medical referral per year
	- Number of all-cause accesses to emergency departments per year,
	- Number of all-cause hospitalizations per year;
	- Death.
Clinical Indicators*	- Time from the diagnosis of T2DM
	- Presence or absence and number of diabetes-related complications
	- Presence or absence and number of co-morbidities;
	- Ongoing medications and number of medications (or injections if patients are treated by insulin);
	- Smoking habits;
	- Glycated haemoglobin (HbA1c);
	- Lipid Profile (Total Cholesterol, HDL Cholesterol, LDL Cholesterol, Triglycerides);
	- Liver Profile (ALT, AST, GGT)
	- Renal Profile (Creatinine, estimated Glomerular Filtration Rate);
	- Height, weight, abdominal circumference and Body Mass Index (BMI);
	- Presence of insulin lipodystrophy;
	- Arterial Blood Pressure and Hearth Rate.
	- Self-care confidence (measured by the Self-Care of Diabetes Index, SCODI);
Person-centered indicators	- Self-care maintenance of diabetes (measured by the Self-Care of Diabetes Index, SCODI);
	- Self-care monitoring of diabetes (measured by the Self-Care of Diabetes Index, SCODI);
	- Self-care management of diabetes (measured by the Self-Care of Diabetes Index, SCODI);
	- Functional status (measured by the SF12 questionnaire);
	- Cognitive status (measured by the SF12 questionnaire);
	- Quality of life (measured by the EQ-5D-3L Quality of life Questionnaire);
	- Diabetes-related distress (measured by the Problem Areas in Diabetes Questionnaire Short Form, PAID-5);
	- Sleep quality (measured by the Pittsburgh Sleep Quality Index, PSQI).
	- Age;
Socio-demographic indicators*	- Gender;
	- Educational level;
	- Employment status;
	- Income level;
	- Presence of formal or informal caregiver.